Lithium Controlled-Release and Extended-Release Tablets and Noctiva
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Noctiva and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: desmopressin
Brand name: DDAVP nasal, DDAVP Rhinal Tube, Noctiva, Stimate, DDAVP, Nocdurna
Synonyms: Noctiva (nasal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Noctiva nasal
- Lithium Controlled-Release and Extended-Release Tablets-Nodolor
- Lithium Controlled-Release and Extended-Release Tablets-Nodolor Capsules
- Lithium Controlled-Release and Extended-Release Tablets-NoDoz
- Lithium Controlled-Release and Extended-Release Tablets-NoHist DM
- Lithium Controlled-Release and Extended-Release Tablets-NoHist LQ
- Noctiva-Lithium ER
- Noctiva-Lithium Oral Solution
- Noctiva-Lithium Salts
- Noctiva-Lithium Syrup and Oral Solution
- Noctiva-Lithobid
- Noctiva-Lithostat